Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
wolf-screen-ratio-mammosphere-adherent | 1.002 | 3.18e-18 | 5.23e-04 | 1.26e-02 |
Gene Symbol | Entrez Gene ID | Frequency | wolf-screen-ratio-mammosphere-adherent gene score | Best subnetwork score | Degree | wolf adherent-list Hits GI | wolf mammosphere no adherent-list Hits GI |
---|---|---|---|---|---|---|---|
ACTB | 60 | 167 | 1.153 | 1.151 | 587 | Yes | - |
RSL24D1 | 51187 | 36 | 1.300 | 1.020 | 59 | Yes | - |
ACO2 | 50 | 50 | 1.000 | 1.076 | 191 | Yes | - |
ATP1A1 | 476 | 2 | 0.842 | 1.002 | 82 | Yes | - |
OGDH | 4967 | 13 | 0.847 | 1.076 | 113 | Yes | - |
[ CFL1 ] | 1072 | 12 | 0.674 | 1.020 | 203 | Yes | - |
PGD | 5226 | 75 | 1.201 | 1.106 | 138 | Yes | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
CFL1 | 1072 | OGDH | 4967 | pp | -- | int.I2D: YeastLow |
ACO2 | 50 | CFL1 | 1072 | pp | -- | int.I2D: YeastLow |
CFL1 | 1072 | RSL24D1 | 51187 | pp | -- | int.I2D: YeastLow |
OGDH | 4967 | PGD | 5226 | pp | -- | int.I2D: YeastLow |
ACTB | 60 | CFL1 | 1072 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, MINT_Yeast, MIPS, BioGrid, BIND_Yeast, HPRD, IntAct, IntAct_Yeast, MINT, VidalHuman_core, YeastLow, Yu_GoldStd; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
ACO2 | 50 | OGDH | 4967 | pp | -- | int.I2D: YeastLow |
ATP1A1 | 476 | CFL1 | 1072 | pp | -- | int.I2D: BCI, BioGrid_Rat, HPRD; int.HPRD: in vitro, in vivo, yeast 2-hybrid |
ACO2 | 50 | PGD | 5226 | pp | -- | int.I2D: YeastLow |
CFL1 | 1072 | PGD | 5226 | pp | -- | int.I2D: YeastLow |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0006099 | tricarboxylic acid cycle | 7.59e-05 | 1.00e+00 | 7.201 | 2 | 4 | 28 |
GO:0006091 | generation of precursor metabolites and energy | 2.45e-04 | 1.00e+00 | 6.365 | 2 | 3 | 50 |
GO:0051087 | chaperone binding | 3.41e-04 | 1.00e+00 | 6.126 | 2 | 6 | 59 |
GO:0045989 | positive regulation of striated muscle contraction | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0019521 | D-gluconate metabolic process | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0031947 | negative regulation of glucocorticoid biosynthetic process | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 5.36e-04 | 1.00e+00 | 5.799 | 2 | 6 | 74 |
GO:0061034 | olfactory bulb mitral cell layer development | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0045252 | oxoglutarate dehydrogenase complex | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 2 | 2 |
GO:0051538 | 3 iron, 4 sulfur cluster binding | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0019322 | pentose biosynthetic process | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 2 | 2 |
GO:0003994 | aconitate hydratase activity | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0044237 | cellular metabolic process | 1.33e-03 | 1.00e+00 | 5.138 | 2 | 5 | 117 |
GO:0001842 | neural fold formation | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:1990239 | steroid hormone binding | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:1903416 | response to glycoside | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 2 | 3 |
GO:0031402 | sodium ion binding | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0031982 | vesicle | 1.67e-03 | 1.00e+00 | 4.975 | 2 | 9 | 131 |
GO:0006104 | succinyl-CoA metabolic process | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 4 |
GO:0006734 | NADH metabolic process | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 4 |
GO:0006102 | isocitrate metabolic process | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 1 | 5 |
GO:0030976 | thiamine pyrophosphate binding | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 1 | 5 |
GO:0045823 | positive regulation of heart contraction | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 1 | 5 |
GO:0021695 | cerebellar cortex development | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 2 | 6 |
GO:0045822 | negative regulation of heart contraction | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 6 |
GO:0030957 | Tat protein binding | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 3 | 6 |
GO:0030836 | positive regulation of actin filament depolymerization | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 2 | 6 |
GO:0006101 | citrate metabolic process | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 6 |
GO:0021860 | pyramidal neuron development | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 6 |
GO:0036376 | sodium ion export from cell | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 6 |
GO:0086013 | membrane repolarization during cardiac muscle cell action potential | 3.39e-03 | 1.00e+00 | 8.201 | 1 | 1 | 7 |
GO:0030955 | potassium ion binding | 3.39e-03 | 1.00e+00 | 8.201 | 1 | 1 | 7 |
GO:0005391 | sodium:potassium-exchanging ATPase activity | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 8 |
GO:0086009 | membrane repolarization | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 8 |
GO:0070688 | MLL5-L complex | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 1 | 8 |
GO:0030042 | actin filament depolymerization | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 2 | 8 |
GO:0006554 | lysine catabolic process | 3.88e-03 | 1.00e+00 | 8.009 | 1 | 2 | 8 |
GO:0030007 | cellular potassium ion homeostasis | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 2 | 9 |
GO:0006098 | pentose-phosphate shunt | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 4 | 10 |
GO:0071383 | cellular response to steroid hormone stimulus | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 10 |
GO:0086004 | regulation of cardiac muscle cell contraction | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 10 |
GO:0005890 | sodium:potassium-exchanging ATPase complex | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 10 |
GO:0021756 | striatum development | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 10 |
GO:0005759 | mitochondrial matrix | 4.96e-03 | 1.00e+00 | 4.176 | 2 | 14 | 228 |
GO:0021794 | thalamus development | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 1 | 11 |
GO:0061001 | regulation of dendritic spine morphogenesis | 5.33e-03 | 1.00e+00 | 7.549 | 1 | 2 | 11 |
GO:0086064 | cell communication by electrical coupling involved in cardiac conduction | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 2 | 12 |
GO:0055119 | relaxation of cardiac muscle | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 12 |
GO:0006883 | cellular sodium ion homeostasis | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 12 |
GO:0060081 | membrane hyperpolarization | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 1 | 12 |
GO:0010107 | potassium ion import | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 1 | 13 |
GO:0002028 | regulation of sodium ion transport | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 1 | 13 |
GO:0035267 | NuA4 histone acetyltransferase complex | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 4 | 14 |
GO:0050998 | nitric-oxide synthase binding | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 16 |
GO:0006103 | 2-oxoglutarate metabolic process | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 16 |
GO:0031258 | lamellipodium membrane | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 2 | 16 |
GO:0022604 | regulation of cell morphogenesis | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 1 | 16 |
GO:0043234 | protein complex | 8.18e-03 | 1.00e+00 | 3.804 | 2 | 18 | 295 |
GO:0002026 | regulation of the force of heart contraction | 8.22e-03 | 1.00e+00 | 6.921 | 1 | 1 | 17 |
GO:0006754 | ATP biosynthetic process | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 1 | 18 |
GO:0016791 | phosphatase activity | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 1 | 18 |
GO:0019901 | protein kinase binding | 9.40e-03 | 1.00e+00 | 3.700 | 2 | 21 | 317 |
GO:0007411 | axon guidance | 9.52e-03 | 1.00e+00 | 3.691 | 2 | 13 | 319 |
GO:0030506 | ankyrin binding | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 1 | 20 |
GO:0043548 | phosphatidylinositol 3-kinase binding | 1.01e-02 | 1.00e+00 | 6.616 | 1 | 2 | 21 |
GO:0030010 | establishment of cell polarity | 1.01e-02 | 1.00e+00 | 6.616 | 1 | 2 | 21 |
GO:0000281 | mitotic cytokinesis | 1.01e-02 | 1.00e+00 | 6.616 | 1 | 1 | 21 |
GO:0030863 | cortical cytoskeleton | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 4 | 22 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.11e-02 | 1.00e+00 | 6.485 | 1 | 4 | 23 |
GO:0030864 | cortical actin cytoskeleton | 1.11e-02 | 1.00e+00 | 6.485 | 1 | 1 | 23 |
GO:0043200 | response to amino acid | 1.11e-02 | 1.00e+00 | 6.485 | 1 | 1 | 23 |
GO:0005925 | focal adhesion | 1.24e-02 | 1.00e+00 | 3.493 | 2 | 19 | 366 |
GO:0050661 | NADP binding | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 2 | 27 |
GO:0031492 | nucleosomal DNA binding | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 4 | 27 |
GO:0001755 | neural crest cell migration | 1.35e-02 | 1.00e+00 | 6.201 | 1 | 2 | 28 |
GO:0043531 | ADP binding | 1.35e-02 | 1.00e+00 | 6.201 | 1 | 1 | 28 |
GO:0019894 | kinesin binding | 1.35e-02 | 1.00e+00 | 6.201 | 1 | 1 | 28 |
GO:0042254 | ribosome biogenesis | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 1 | 30 |
GO:0031072 | heat shock protein binding | 1.59e-02 | 1.00e+00 | 5.964 | 1 | 1 | 33 |
GO:0044281 | small molecule metabolic process | 1.60e-02 | 1.00e+00 | 2.352 | 3 | 58 | 1211 |
GO:0001895 | retina homeostasis | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 1 | 34 |
GO:0051539 | 4 iron, 4 sulfur cluster binding | 1.69e-02 | 1.00e+00 | 5.879 | 1 | 3 | 35 |
GO:0034332 | adherens junction organization | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 36 |
GO:0070062 | extracellular vesicular exosome | 1.75e-02 | 1.00e+00 | 1.780 | 4 | 104 | 2400 |
GO:0030315 | T-tubule | 1.78e-02 | 1.00e+00 | 5.799 | 1 | 1 | 37 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.78e-02 | 1.00e+00 | 5.799 | 1 | 4 | 37 |
GO:0021766 | hippocampus development | 1.83e-02 | 1.00e+00 | 5.761 | 1 | 4 | 38 |
GO:0006096 | glycolytic process | 1.83e-02 | 1.00e+00 | 5.761 | 1 | 4 | 38 |
GO:0070527 | platelet aggregation | 1.83e-02 | 1.00e+00 | 5.761 | 1 | 2 | 38 |
GO:0007596 | blood coagulation | 1.88e-02 | 1.00e+00 | 3.179 | 2 | 18 | 455 |
GO:0060048 | cardiac muscle contraction | 1.88e-02 | 1.00e+00 | 5.723 | 1 | 1 | 39 |
GO:0021762 | substantia nigra development | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 2 | 44 |
GO:0007266 | Rho protein signal transduction | 2.26e-02 | 1.00e+00 | 5.454 | 1 | 2 | 47 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 2.54e-02 | 1.00e+00 | 5.281 | 1 | 5 | 53 |
GO:0045216 | cell-cell junction organization | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 2 | 54 |
GO:0031966 | mitochondrial membrane | 2.64e-02 | 1.00e+00 | 5.227 | 1 | 1 | 55 |
GO:0008217 | regulation of blood pressure | 2.73e-02 | 1.00e+00 | 5.176 | 1 | 4 | 57 |
GO:0005901 | caveola | 2.97e-02 | 1.00e+00 | 5.055 | 1 | 5 | 62 |
GO:0071260 | cellular response to mechanical stimulus | 3.11e-02 | 1.00e+00 | 4.986 | 1 | 5 | 65 |
GO:0045087 | innate immune response | 3.12e-02 | 1.00e+00 | 2.790 | 2 | 24 | 596 |
GO:0034329 | cell junction assembly | 3.25e-02 | 1.00e+00 | 4.921 | 1 | 1 | 68 |
GO:0032587 | ruffle membrane | 3.35e-02 | 1.00e+00 | 4.879 | 1 | 3 | 70 |
GO:0042383 | sarcolemma | 3.40e-02 | 1.00e+00 | 4.859 | 1 | 3 | 71 |
GO:0016020 | membrane | 3.85e-02 | 1.00e+00 | 1.879 | 3 | 90 | 1681 |
GO:0002576 | platelet degranulation | 3.91e-02 | 1.00e+00 | 4.651 | 1 | 4 | 82 |
GO:0016311 | dephosphorylation | 4.05e-02 | 1.00e+00 | 4.599 | 1 | 3 | 85 |
GO:0007010 | cytoskeleton organization | 4.33e-02 | 1.00e+00 | 4.501 | 1 | 1 | 91 |
GO:0042470 | melanosome | 4.33e-02 | 1.00e+00 | 4.501 | 1 | 9 | 91 |
GO:0016363 | nuclear matrix | 4.33e-02 | 1.00e+00 | 4.501 | 1 | 12 | 91 |
GO:0006928 | cellular component movement | 4.33e-02 | 1.00e+00 | 4.501 | 1 | 7 | 91 |
GO:0005200 | structural constituent of cytoskeleton | 4.33e-02 | 1.00e+00 | 4.501 | 1 | 8 | 91 |
GO:0014069 | postsynaptic density | 4.99e-02 | 1.00e+00 | 4.294 | 1 | 3 | 105 |
GO:0005506 | iron ion binding | 4.99e-02 | 1.00e+00 | 4.294 | 1 | 4 | 105 |
GO:0072562 | blood microparticle | 5.27e-02 | 1.00e+00 | 4.214 | 1 | 3 | 111 |
GO:0030529 | ribonucleoprotein complex | 5.31e-02 | 1.00e+00 | 4.201 | 1 | 8 | 112 |
GO:0006325 | chromatin organization | 5.59e-02 | 1.00e+00 | 4.126 | 1 | 5 | 118 |
GO:0030036 | actin cytoskeleton organization | 5.82e-02 | 1.00e+00 | 4.066 | 1 | 5 | 123 |
GO:0009615 | response to virus | 5.96e-02 | 1.00e+00 | 4.031 | 1 | 5 | 126 |
GO:0000790 | nuclear chromatin | 6.10e-02 | 1.00e+00 | 3.998 | 1 | 9 | 129 |
GO:0016323 | basolateral plasma membrane | 6.37e-02 | 1.00e+00 | 3.932 | 1 | 4 | 135 |
GO:0005911 | cell-cell junction | 6.42e-02 | 1.00e+00 | 3.921 | 1 | 4 | 136 |
GO:0006457 | protein folding | 6.74e-02 | 1.00e+00 | 3.849 | 1 | 7 | 143 |
GO:0061024 | membrane organization | 6.83e-02 | 1.00e+00 | 3.829 | 1 | 7 | 145 |
GO:0034220 | ion transmembrane transport | 7.01e-02 | 1.00e+00 | 3.790 | 1 | 4 | 149 |
GO:0005615 | extracellular space | 7.39e-02 | 1.00e+00 | 2.106 | 2 | 17 | 957 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 7.74e-02 | 1.00e+00 | 3.642 | 1 | 7 | 165 |
GO:0030424 | axon | 7.79e-02 | 1.00e+00 | 3.634 | 1 | 4 | 166 |
GO:0005768 | endosome | 7.92e-02 | 1.00e+00 | 3.608 | 1 | 6 | 169 |
GO:0005739 | mitochondrion | 7.96e-02 | 1.00e+00 | 2.046 | 2 | 28 | 998 |
GO:0034641 | cellular nitrogen compound metabolic process | 8.01e-02 | 1.00e+00 | 3.591 | 1 | 20 | 171 |
GO:0019904 | protein domain specific binding | 8.37e-02 | 1.00e+00 | 3.525 | 1 | 6 | 179 |
GO:0016324 | apical plasma membrane | 9.27e-02 | 1.00e+00 | 3.372 | 1 | 5 | 199 |
GO:0030168 | platelet activation | 9.54e-02 | 1.00e+00 | 3.329 | 1 | 10 | 205 |
GO:0005975 | carbohydrate metabolic process | 1.17e-01 | 1.00e+00 | 3.026 | 1 | 9 | 253 |
GO:0003779 | actin binding | 1.22e-01 | 1.00e+00 | 2.953 | 1 | 12 | 266 |
GO:0005524 | ATP binding | 1.25e-01 | 1.00e+00 | 1.667 | 2 | 60 | 1298 |
GO:0042493 | response to drug | 1.30e-01 | 1.00e+00 | 2.859 | 1 | 13 | 284 |
GO:0005856 | cytoskeleton | 1.33e-01 | 1.00e+00 | 2.824 | 1 | 12 | 291 |
GO:0055114 | oxidation-reduction process | 1.87e-01 | 1.00e+00 | 2.294 | 1 | 12 | 420 |
GO:0043066 | negative regulation of apoptotic process | 1.89e-01 | 1.00e+00 | 2.281 | 1 | 31 | 424 |
GO:0055085 | transmembrane transport | 1.93e-01 | 1.00e+00 | 2.244 | 1 | 10 | 435 |
GO:0006468 | protein phosphorylation | 2.03e-01 | 1.00e+00 | 2.163 | 1 | 18 | 460 |
GO:0044267 | cellular protein metabolic process | 2.09e-01 | 1.00e+00 | 2.120 | 1 | 29 | 474 |
GO:0005783 | endoplasmic reticulum | 2.41e-01 | 1.00e+00 | 1.890 | 1 | 10 | 556 |
GO:0005794 | Golgi apparatus | 2.61e-01 | 1.00e+00 | 1.756 | 1 | 15 | 610 |
GO:0005829 | cytosol | 3.48e-01 | 1.00e+00 | 0.723 | 2 | 132 | 2496 |
GO:0005634 | nucleus | 3.90e-01 | 1.00e+00 | 0.439 | 3 | 136 | 4559 |
GO:0005654 | nucleoplasm | 4.21e-01 | 1.00e+00 | 0.929 | 1 | 76 | 1082 |
GO:0046872 | metal ion binding | 4.86e-01 | 1.00e+00 | 0.657 | 1 | 25 | 1307 |
GO:0005730 | nucleolus | 5.71e-01 | 1.00e+00 | 0.328 | 1 | 69 | 1641 |
GO:0005737 | cytoplasm | 5.83e-01 | 1.00e+00 | 0.130 | 2 | 110 | 3767 |
GO:0005515 | protein binding | 6.18e-01 | 1.00e+00 | 0.037 | 3 | 184 | 6024 |
GO:0016021 | integral component of membrane | 6.45e-01 | 1.00e+00 | 0.056 | 1 | 27 | 1982 |
GO:0005886 | plasma membrane | 7.49e-01 | 1.00e+00 | -0.326 | 1 | 45 | 2582 |